Pneumococcal vaccination for welders: Global deployment within a multi‐national corporation

Background Lobar pneumonia is an occupational disease of welders. This is the first report of global deployment of a pneumococcal vaccination program for welders within a multi‐national corporation. Methods Global webinars were conducted to introduce the program. Communication packages translated in...

Full description

Saved in:
Bibliographic Details
Published in:American journal of industrial medicine 2019-01, Vol.62 (1), p.69-73
Main Authors: Donoghue, A. Michael, Wesdock, James C.
Format: Article
Language:English
Subjects:
Australia
Brazil
Canada
Europe
Health care facilities
Humans
Immunization
Metal workers
Occupational diseases
Occupational Diseases - microbiology
Occupational Diseases - prevention & control
pneumococcal
Pneumococcal Vaccines
Pneumonia
Pneumonia, Pneumococcal - prevention & control
Polysaccharides
Site location
Streptococcus infections
United States
Vaccination
Vaccination Coverage - statistics & numerical data
Vaccines
welder
Welding
Welding machines
Working hours
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Lobar pneumonia is an occupational disease of welders. This is the first report of global deployment of a pneumococcal vaccination program for welders within a multi‐national corporation. Methods Global webinars were conducted to introduce the program. Communication packages translated into all location languages were deployed. All employee welders who had not previously been vaccinated were offered a free single dose of pneumococcal polysaccharide vaccine (PPV23) by on‐site location medical centers during normal working hours. Numbers of vaccinated welders were reported by each location each month. Results Twelve months after starting the program, 241 of 767 welders have been vaccinated (31%) across six countries. Conclusions Global deployment of pneumococcal vaccination for welders can be successfully undertaken by a multi‐national corporation. Adoption of this practice by corporations could reduce the incidence and mortality of pneumonia among welders globally.
ISSN:0271-3586
1097-0274
DOI:10.1002/ajim.22934